EL MONTE, CA, September 11, 2026 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to honor Tenghuan Ge, MBA, with inclusion in Who's Who in the World. An accomplished listee, Ms. Ge celebrates many years' experience in her professional network and has been noted for achievements, leadership qualities, and the credentials and successes she has accrued in her field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Ge's career is marked by a steady ascent through roles of increasing responsibility and impact in both academic and entrepreneurial settings. Since 2026, she has served as a senior project manager at the Biomedical Informatics and Genomics Center at Tulane University in New Orleans. In this capacity, Ms. Ge manages funding allocation, oversees project expenses, allocates budgets across salaries and projects, maintains and trains new lab staff, and collaborates across departments to ensure efficient resource utilization.
Before joining Biomedical Informatics, Ms. Ge co-founded Zermatt Biotech in 2025, where she serves as the chief executive officer. Under her leadership, the company has focused on developing central nervous system-optimized inhibitors for neuroinflammatory diseases. Zermatt Biotech's proprietary platform combines artificial intelligence-driven medicinal chemistry with patient-derived organoid validation to address the challenge of overcoming the blood-brain barrier, targeting critical unmet needs in pediatric and adult neurological disorders.
Prior to her current positions, Ms. Ge founded Fadednight Event from 2021 to 2023, an event planning company that she built from inception into a recognized brand. She generated revenue and expanded the business over two years, which stands as one of her proudest achievements.
Ms. Ge held several positions at the University of Southern California between 2019 and 2026, including cell engineering and regeneration core manager at the Keck School of Medicine. She also served as a project manager, laboratory manager, technician and research assistant during this period. Ms. Ge's responsibilities included managing laboratory operations and supporting research initiatives across various departments.
Earlier in her professional journey, Ms. Ge was a project manager at the Chinese Academy of Sciences at Xuhui Central Hospital from 2015 to 2016. In addition to these primary roles, she contributed her expertise as a financial adviser at UltraX in Austin, Texas, and as a business strategy consultant for Stämm in San Francisco, both in 2023.
Ms. Ge's academic background has been instrumental in shaping her multidisciplinary approach to science and business. Her academic foundation was established with a Bachelor of Science in bioengineering from the University of California, Riverside, in 2012. Subsequently, Ms. Ge completed a Master of Science in chemical engineering at the University of California, Irvine, in 2015 and a Master of Business Administration from the University of Southern California in 2025, which broadened her perspective beyond traditional scientific boundaries and enabled her to pursue leadership opportunities in biotech entrepreneurship.
Beyond her professional responsibilities, Ms. Ge is active within civic-minded organizations, such as the SoCal Medtech Association, where she has served as a venture scout since 2025. Her contributions extend to scholarly publications as well. Ms. Ge co-authored 'Mild Traumatic Brain Injury Induces Microvascular Injury and Accelerates Alzheimer-Like Pathogenesis in Mice,' published by Acta Neuropathologica Communications in 2021, 'Atp13a5 Marker Reveals Pericyte Specification in the Mouse Central Nervous System,' featured in the Journal of Neuroscience in 2024, and 'Functional Hydrogel for Modulating Lipid Droplets and Neuroinflammation in Head Injury,' published in Advanced Functional Materials in 2025. Additional works are currently under review or available as preprints.
Ms. Ge's decision to enter biomedical science was inspired by personal experience after immigrating to America from China during junior high school. Witnessing her elderly landlord's struggle with Alzheimer's disease motivated her to understand neurodegenerative conditions more deeply and ultimately led her to pursue advanced education and research aimed at improving health care outcomes.
Throughout her professional journey, Ms. Ge has demonstrated expertise in project management as well as biomedical research and innovation. Among her most significant accomplishments was being granted a patent for the generation of STING inhibitors in 2025. She has also been recognized for mentoring high school and college students through various programs, such as the Brain Bee competition. Notably, students who have volunteered in Ms. Ge's laboratory have gone on to attend prestigious institutions, including the Massachusetts Institute of Technology and the California Institute of Technology.
Ms. Ge's work has been recognized with several honors in 2025, including a Small Business Innovation Reward from the USC Office of Research and a Third Place award in the Joint Venture Negotiation Competition. That same year, she was selected as a semi-finalist in the USC New Venture Seed Competition and was a national finalist for the Hult Prize International. Ms. Ge attributes her success to open-mindedness and a willingness to challenge traditional scientific norms. She encourages others, especially younger generations, to recognize that diverse career paths exist beyond conventional expectations.
Eager for the future, Ms. Ge remains committed to bridging scientific projects with business initiatives while educating future generations about science and innovation beyond prevailing narratives on social media platforms. Her ongoing dedication reflects both personal resilience and a drive to inspire others through example.
# # #